360P ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib
Zofia Piotrowska(Massachusetts General Hospital), M-J. Ahn, Y-K. Pang, S.H. How, K. Sang-We, P.J. Voon, D.L. Cortinovis, J. De Castro Carpeño, M. Tiseo, D. Rodriguez Abreu, S.S. Ramalingam, J. Li, L. Servidio, S. Sadow, R.J. Hartmaier, B.C. Cho
Cited by 7Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis